Week 94 Review

A relatively quiet week, especially compared to last week. The combined portfolios ended up £473.60 better off with a total value of £64,831 and standing £3,537 in the black.

There were no double-digit losers, but with OPTI:Optibiotix dropping 6%, SKIN:SkinBiotherapeutics dropping 9% and KIBO:Kibo Mining dropping 5% it could easily have been a red week. However, this week's only double-digit riser and Share of the Week was AMYT:Amryt Pharma which soared 22%, taking paper profits to £2,445 and making it my 2nd best performer after IQE:IQE. The 4p rise that lifted it to 26p was worth over £1,300, and with brokers suggesting 60p+ as target price, this could quite quickly add another £14,000 over the next few years.

I ought to give GVC:GVC Holdings a mention too. A 7% rise this week saw the price go to 811p, so with my original purchase price of 420p this has nearly doubled. If I hadn't bedded it into my ISA and taken a chunk of the profits from paper to real, this would be up there competing with AMYT:Amryt Pharma for 2nd best performer, and it's paid out £142 in dividends too.

The gap is back!

The ISA and share accounts look like this

			Weekly Change
Portfolio cost	£42,839.83		+£269.69
Portfolio sell value (bid price - commission)	£44,208.79	(+3.2%)	+£827.47
Potential profits	£6,082.61		+£1,586.90
Yr 2 Dividends	£458.94		+£0
Yr 2 Profit from sales	£2,401.06		+£0
Yr 2 Average monthly cash profit	£291.60		-£7.11
Yr 2 Avg annual % of current portfolio cost	8.2%
Total Dividends	£1,126.87		+£0
Total Profit from sales	£6.241.32		+£0
Average monthly cash profit	£335.83		-£3.61
(Sold stocks profit + Dividends - Fees / Months)
Avg annual % of current portfolio cost	9.4%

I added £269 to buy some more CMCL:Caledonia Mining before the share consolidation. Potential profits were up a massive £1,586 thanks to AMYT:Amryt Pharma and GVC:GVC Holdings, but half of that was zapped by the increased losses I mentioned above. No sales or dividends, so a slight tick down in performance and I'm still conscious I need to get the average back above 10%.

After the panic of 2 weeks ago, the recovery has been most satisfying, and don't forget there's the £1,100 loss from the AFG:Aquatic Food disaster lost in the middle of that lot somewhere, causing barely a ripple in the lines.

The SIPP looks like this after week 78

			Weekly Change
Portfolio cost	£17,468.71		+£0
Portfolio sell value (bid price - commission)	£19,787.19	(+13.3%)	-£315.77
Potential profits	£3,082.20		-£277.42
Yr 2 Dividends	£0		+£0
Yr 2 Profit from sales	£1,596.81		+£0
Yr 2 Average monthly cash profit	£258.98		-£10.36
Yr 2 Avg annual % of current portfolio cost	17.8%
Total Dividends	£413.19		+£0
Total Profit from sales	£3,946.67		+£0
Average monthly cash profit	£237.01		-£3.08
(Sold stocks profit + Dividends - Fees / Months)
Avg annual % of current portfolio cost	16.3%

The pension didn't have the protection of AMYT:Amryt Pharma and so the drop in OPTI:Optibiotix did a lot of damage. There were small drops in the loss-making shares too, which dragged the portfolio value down despite another tick up for IQE:IQE.

If I can maintain this gap for a while I'll be happy.

The dreaded trading account looks like this after week 44

			Weekly Change
Portfolio cost	£986.03		+£0
Cash	£79.63		+£0
Portfolio sell value (bid price - commission)	£835.79	(-15.2%)	-£38.10
Potential profits	£0		+£0
Dividends	£0		+£0
Profit from sales	-£22.85		+£0
Average monthly cash profit	-£2.25		+£0.05
(Sold stocks profit + Dividends - Fees / Months)
Avg annual % of current portfolio cost	-2.87%

What an unmitigated disaster. Nearly a year and I've managed to make a loss from sales thanks to pulling my JLP:Jubilee Platinum shares out of this account into my ISA and the other 2 absolutely refuse to get into profit while I sit impotently waiting for something interesting to do. I'm such a shit trader! Glad this experiment is with a small percentage of my savings.

Pants!

Next week is a short week with the bank holiday, and none of my shares are due to report so it could be a quiet one as we await the general election. It would be nice if AMYT:Amryt Pharma could do an IQE:IQE and slowly creep upwards, as that will protect my buffer from volatility elsewhere. There's a risk of profit taking though, as the FAST:Fastnet Equity reverse takeover price was 24p so the long-term holders that might be feeling impatient could start to bale as we climb towards 30p. In my opinion that would be rather premature, as this company has potential to deliver astounding shareholder value for those invested from the start.

OPTI:Optibiotix continues to perplex. News of contracts coming after the Vitafoods exhibition could give us a boost, and the long-awaited news of free SKIN:SkinBiotherapeutics shares would be most welcome. Murmurings on the bulletin board suggest that the attempts to reward long-term holders over and above day traders are not going to be realised, which is a shame, but I'd really like to know what we're going to get so I can make some decisions on whether to buy any more SKIN:SkinBiotherapeutics shares on the market while they are below my initial buying price.

Forced to buy more gold

There was an RNS this morning from CMCL:Caledonia Mining to say they were planning to list on the New York Stock Exchange. As the minimum value per share is $2 with a preference for $5 they are doing a share consolidation prior to the listing.

At first this seemed fine, until I read the details.

It's one share for every five, however, rather than just do that they are initially doing one for every hundred, and then multiplying that by 20.

Yeah right - I had 737, so after paying 135p per share I'm going to let 37 of them sell for 94p - I think not!

I loaded £200 into my ISA from my current account and bought 263 at 98p costing £269.69. This brings my total up to a nice round 1,000 shares. That will go down to 10 on the initial consolidation, then up to 200 on the second phase, with no loss of shares.

The effect was to bring my average price down from 135p to 125.3p so I'm hoping the new liquidity of listing in America along with a gold rally will get these back to profit. I did rather buy on a spike! Although miffed at the price I originally paid, I'm not too concerned as the P/E ratio is just 10.7 and that's based on the price of gold last year. With production ramping up a P/E ratio of 15 would be worth about 350p, and while there's risk with their country of operation which will likely keep the price down, my target is at least 250p, around double what I paid.

I do like this as a gold share, with a quarterly dividend of £8 just ticking along nicely. It's not as good a return as PAF:Pan African Resources but I think a bit less risky, despite being in Zimbabwe. Having said that, the PAF:Pan African Resources dividend is so good, I'm tempted to get back in just before the October ex-date if the price doesn't go mad.

KAT:Katoro Gold dropped 2.5% today. I'm keeping an eye on this one, but as I'm expecting a decent chunk of free shares from KIBO:Kibo Mining I won't be buying any. However, if the price drops much further it might be one for the trading account!

At the halfway point, this week is looking OK. The combined portfolios are up by £395, with AMYT:Amryt Pharma doing particularly well. OPTI:Optibiotix has slipped a bit else things would be looking much better.

I was quite shocked to see VEC:Vectura has dropped to 120p on the news that the Americans have rejected their joint bid with HIK:Hikma Pharma to sell a generic version of Advair, until now protected by patents. The share price has dropped from 150p to 120p which seems a bit of an over-reaction. I sold my holding at 153p for a £89 loss, but am keeping an eye on this, as although the rejection will cost them this year, they are likely to get approval eventually so a recovery seems on the cards. The question is how much lower will it go beforehand?

I do like to keep track of my old shares. Sometimes it's painful, when I see TON:Titon Holdings at 165p after I sold at 101p and 91p, although that was still 15% profit. Sometimes I'm filled with relief that I got out in time, like with AFG:Aquatic Food which has dropped even further, or RCI:Rapidcloud which has vanished but gave me an 11.4% profit. AVM:Avocet Mining was another close one, yielding just a 3.5% profit but that would now be a 50% loss. It's amazing how many of them are pretty much the same price as when I sold though.

Right - time to don my Man Utd top, crack open a beer and prepare for the most important game we've had for many a year!

Week 93 Review - Best ever week?

What an amazing week. the review is late as I've been on holiday, but there was much giggling as I checked my portfolio and watched OPTI:Optibiotix climb relentlessly back into profit. Nemesis Share - what Nemesis Share? The combined portfolios ended up a staggering £3,185.84 better off than last week, £3,063 in the black with a value of £64,088.48. Woohoo!!

No double-digit losers this week, and both double-digit risers are related. OPTI:Optibiotix made a triumphant return to profit and rewarded all the 64p purchases by leaping 15% to 77p and is now £956 in profit. The worm has well and truly turned!

Share of the Week is an offspring of OPTI:Optibiotix, with SBTX:SkinBiotherapeutics climbing 24%. This is still 10% down on my purchase but on the way to recovery.

That's more like it!

The ISA and share accounts look like this

			Weekly Change
Portfolio cost	£42,570.14		+£13.23
Portfolio sell value (bid price - commission)	£43,111.63	(+1.3%)	+£2,128.18
Potential profits	£4,495.71		+£443.29
Yr 2 Dividends	£458.94		+£93.90
Yr 2 Profit from sales	£2,401.06		+£0
Yr 2 Average monthly cash profit	£298.71		+£2.71
Yr 2 Avg annual % of current portfolio cost	8.4%
Total Dividends	£1,126.87		+£93.90
Total Profit from sales	£6.241.32		+£0
Average monthly cash profit	£338.94		+£0.74
(Sold stocks profit + Dividends - Fees / Months)
Avg annual % of current portfolio cost	9.6%

Portfolio cost went up due to the open offer for RDT:Rosslyn Data. Although I don't hold out a huge amount of hope, the chance of increasing my holding by 10% for hardly any money and no commission had to be taken and brought the average price down from 17.52p to 15.85p. They are still 70% down though.

A staggering increase in value of £2,128 has brought the accounts back into the black. Hopefully this time it will last longer than a week! Of that, only £443 was increased profit. Most of it was reduction in loss for OPTI:Optibiotix, SBTX:SkinBiotherapeutics and KIBO:Kibo Mining.

There were lots of dividends this week, with £72.86 from GVC:GVC Holdings, £13.74 from TW.:Taylor Wimpey and £7.30 from BDEV:Barratt Developments, adding up to £93.90. This allowed the average monthly performance to creep up instead of the usual dip. I'm still below the target 10% though.

You might call this one volatile! All I can do is hope the green holds above the red for a while this time.

The SIPP looks like this after week 77

			Weekly Change
Portfolio cost	£17,468.71		+£0
Portfolio sell value (bid price - commission)	£20,102.96	(+15.1%)	+£1,061.39
Potential profits	£3,359.62		+£725.26
Yr 2 Dividends	£0		+£0
Yr 2 Profit from sales	£1,596.81		+£0
Yr 2 Average monthly cash profit	£269.34		-£11.23
Yr 2 Avg annual % of current portfolio cost	18.5%
Total Dividends	£413.19		+£0
Total Profit from sales	£3,946.67		+£0
Average monthly cash profit	£240.09		-£3.16
(Sold stocks profit + Dividends - Fees / Months)
Avg annual % of current portfolio cost	16.5%

A superb £1,061 rise in value, £725 of which were increased profits and most of that was OPTI:Optibiotix, with a contribution from IQE:IQE which continued to climb, although much slower than recently. Performance took the usual slight dip due to no sales or dividends.

The gap isn't the widest it's been, but not far off.

The trading account looks like this after week 43

			Weekly Change
Portfolio cost	£986.03		+£0
Cash	£79.63		+£0
Portfolio sell value (bid price - commission)	£873.89	(-11.4%)	-£3.73
Potential profits	£0		+£0
Dividends	£0		+£0
Profit from sales	-£22.85		+£0
Average monthly cash profit	-£2.30		+£0.06
(Sold stocks profit + Dividends - Fees / Months)
Avg annual % of current portfolio cost	-2.8%

The increase in KIBO:Kibo Mining was offset by the drop in REDS:RedstoneConnect resulting in a drop of £3.73.

I think you can call this consistent - consistently rubbish!

No time to ponder what might happen next week as it's already next week now. A luke-warm start to the week today, but nothing to put the new super-buffer under threat.

The buffer is back

Today has been a truly remarkable day, with the majority of my key holdings ending blue and the combined portfolios soaring back into the black, with a buffer of £1,180.

I have had similar buffers wiped out in a day before, and the fact it only took a day to generate also points to the risk of it being ephemeral.

Today's price rises mean there has been a change in Nemesis Share. OPTI:Optibiotix has rewarded my faith and all the 64p top-ups by climbing to a bid price of 70p. Last week this was firmly ensconced as Nemesis Share with a £2,681 paper loss.

That was last Wednesday.

Today the loss is reduced to £635 and nowhere near Nemesis Share. With the value rising by £200 for every penny the share price rises, I suspect it may be contending for Star Share soon.

There are three shares performing worse than OPTI:Optibiotix.

LOOK:Lookers is losing £636 so is marginally worse, although you could argue that with £42 dividends this one is beating OPTI:Optibiotix, but showing absolutely no sign of recovering from the post-Brexit slump.

Basket case AFPO:African Potash is second to bottom of the pile, losing £714 and given it's close to going bust is unlikely to be in the portfolio much longer.

So the Nemesis Share title returns to KIBO:Kibo Mining, with paper losses of £814. I'm convinced these are under attack the same way as OPTI:Optibiotix are, but I'm anticipating a rise up to the launch of KAT:Katoro Mining on 23rd May in case that turns out to be the ex-date for free shares. This won't be Nemesis Share for long and climbed 5% today.

I have to mention Star Share, because IQE:IQE is absolutely staggering. It just won't stop going up! Today saw a 6.3% climb, taking the profit in my ISA to 137% and my SIPP to 48% and a total paper profit of £3,967. I can't believe that I nearly didn't buy them for my SIPP as I thought they had peaked. It was the global dominance in a field with high barriers to entry and  soaring worldwide demand for its products that convinced me. Not unlike OPTI:Optibiotix! Every 1p rise in IQE:IQE  is worth £121, and it's averaging more than that every day.

Last time I was this upbeat it all came crashing down around me. I really hope that doesn't happen this time...

Week 92 Review - Partial recovery

A strong end to the week saw about half last week's losses recovered. Overall there was a £1,221.81 gain in portfolio value to £60,889.41 which is just £122.23 in the red.

There were no double-digit losers this week, and lots os small gains, however a big chunk of the recovery came from the double-digit risers. KIBO:Kibo Mining climbed 11% but is still making an overall loss. It did have a very positive impact on the paper losses though.

Share of the Week is IQE:IQE, which climbed 14% and every time I think it's run out of steam, the price carries on rising. The ISA holding is now 120% up on when I bought at 29.6p, with a bid price of 65.75p.

Hopefully nothing horrid will happen next week and we can get back in the black.

The ISA and share accounts look like this

			Weekly Change
Portfolio cost	£42,556.91		-£19.74
Portfolio sell value (bid price - commission)	£40,970.22	(-3.7%)	+£1,019.32
Potential profits	£4,052.42		+£547.17
Yr 2 Dividends	£365.04		+£0
Yr 2 Profit from sales	£2,401.06		-£23.37
Yr 2 Average monthly cash profit	£296.00		-£10.61
Yr 2 Avg annual % of current portfolio cost	8.3%
Total Dividends	£1,032.97		+£0
Total Profit from sales	£6.241.32		-£23.37
Average monthly cash profit	£338.20		-£5.01
(Sold stocks profit + Dividends - Fees / Months)
Avg annual % of current portfolio cost	9.5%

The small drop in cost was due to making a small loss of £23.37 selling TW.:Taylor Wimpey, which was offset by the dividends. The proceeds were all re-invested in OPTI:Optibiotix which ended up by just 1p from last week, but the new shares were bought 1.5p cheaper than that price, so are already contributing towards reducing the Optibiotix losses. Portfolio value up by £1,019, of which about half was increased profit (mainly IQE:IQE) and half was reduced losses (mainly KIBO:Kibo Mining). No dividends so performance drops a little more than usual, and profits of 9.5% are 0.5% below my target, so I need to consider how best to rectify that.

Nice to see the green line going in the right direction again after a few torrid weeks.

The SIPP looks like this after week 76

			Weekly Change
Portfolio cost	£17,468.71		-£28.15
Portfolio sell value (bid price - commission)	£19,041.57	(+9.0%)	+£110.27
Potential profits	£2,634.36		+£8.03
Yr 2 Dividends	£0		+£0
Yr 2 Profit from sales	£1,596.81		+£69.26
Yr 2 Average monthly cash profit	£280.57		+£0.86
Yr 2 Avg annual % of current portfolio cost	19.3%
Total Dividends	£413.19		+£0
Total Profit from sales	£3,946.67		+£69.26
Average monthly cash profit	£243.25		+£0.76
(Sold stocks profit + Dividends - Fees / Months)
Avg annual % of current portfolio cost	16.7%

The cost dropped because when I tried to re-invest the proceeds from selling some JLP:Jubilee Platinum in OPTI:Optibiotix I had to leave a limit order and was expecting to pay 66p but ended up paying 64.28p stranding some cash in my account. Overall a very quiet week, with an increase in value of just £110, but there's also the £69.26 profit taken. The effect on performance was negligible. Instead of the usual drops, performance improved by just 86p a month for year 2 and 76p a month overall.

Just need the two lines to start repelling each other and move apart.

The trading account looks like this after week 42

			Weekly Change
Portfolio cost	£986.03		+£0
Cash	£79.63		+£0
Portfolio sell value (bid price - commission)	£877.62	(-11.0%)	+£72.48
Potential profits	£0		+£0
Dividends	£0		+£0
Profit from sales	-£22.85		+£0
Average monthly cash profit	-£2.36		+£0.06
(Sold stocks profit + Dividends - Fees / Months)
Avg annual % of current portfolio cost	-2.9%

KIBO:Kibo Mining had a good week, so things are on the mend. So far this excercise is just proving the point that day trading is really hard, especially when you're not prepared to take a loss and end up stuck with shares for months. Having this sacrificial account is great though, as it allows me to focus my other accounts on long term investments without tempation to trade.

That's looking a little more promising now.

I was feeliong quite rebellious this week, mainly down to the strife with OPTI:Optibiotix appearing to be attacked, and I believe the same thing was happening to KIBO:Kibo Mining, although the main troll on their bulletin board was just a plain dickhead and I suspect too thick to be involved in shorting. He could have been taking cash from someone to spout gibberish on the bulletin board though. His attempts to post on half a dozen threads in order to hide the main thread seem to have failed miserbly, and it's pleasing that Kibo has recovered so well this week. With KAT:Katoro Mining listing from the reverse takeover of OPRA:Opera Investments on 23rd May, an announcement on share distribution to Kibo holders should see the price sneak a bit higher.

OPTI:Optibiotix had a great end to the week. If the shares were under attack, it's possible that is over, although a new troll has appeared on the bulletin board today, so it may be a while before things settle down. Each 1p recovery is now worth over £200, and the price needed to get back into profit is a few pence lower thanks to the 64p puchases this week. The best possible news next week would be the announcement of how SBTX:SkinBiotherapeutics shares are to be distributed amongst Optibiotix holders, and news on sales of LP_LDL^® following last week's launch and opportunity to do deals at the Vitafoods show alongside new partners Nutrilinea.

Piled in to Optibiotix while it's cheap

I was enraged last night as I saw the OPTI:Optibiotix closing share price. On the day of a massive announcement that Nutrilinea will distribute LPLDL the new cardiovascular & cholesterol strain, the price plummeted!

I was dumbfounded - how can this constant barrage of good news result in the price going down relentlessly?

I began to smell a rat. A combination of factors. Over the last 3 weeks 470,000 shares have been "sold" in blocks of 10,000, and each time it seems to be dragging down the share price. Why would someone offloading choose to do that? Surely they would let the price rise, sell a batch and give it a chance to go up again before selling the next lot. To my (untrained) eyes this looks more like a concerted attack on the share.

OPTI:Optibiotix has 78.54 million shares in circulation. That's not a lot really. It's also relatively lightly traded, so a constant trickle of sizable blocks of shares coming onto the market will have an impact.

It's not a dead cert though - even taking out all the 10,000 blocks, there have been more sells than buys over the last three weeks, or at least trades reported as sells rather than buys, which are often incorrect.

As an aside, that's bloody ridiculous. Why are sites reporting buys and sells not able to state with certainty if it's a buy or sell? There's no reason to hide the reality, unless you want to manipulate people's perception of what's going on? The greatest gift that could be given to private investors would be a reform of this arcane practice and some real data to base our investment decisions on. It's madness that we're risking thousands of pounds on decisions informed by guesswork of what might have been bought or sold in a day. There you go ShareProphets - if you want to pick a fight with the establishment in order to help private investors, that's one that would be truly revolutionary!

Meanwhile, back on topic, and my supposition that there's share price manipulation going on here. I love reading bulletin boards. They are fun, and as long as you're careful with what you believe, they are informative too. The OPTI:Optibiotix bulletin board has some superb informed posters.

A while back on the GVC:GVC Holdings bulletin board, a load of trolls appeared claiming that GVC were about to be prosecuted. There was a constant barrage of negativity furiously denied by the regular posters. Over a four month period the share price dropped from around 750p to 600p. I wasn't overly concerned, having bought all mine at 422p, but it did hammer my paper profits. There was no reason for the decline, and exasperation was rife on the bulletin board from long term holders. Throughout this the trolls continued their drip drip drip of negativity.

Then it stopped. The trolls went away, and the share price has gone from 600p to 766p in 3.5 months.

So what was that all about?

If that wasn't a concerted shorting attack I don't know what it was.

Trolls have now invaded the OPTI:Optibiotix bulletin board. Exactly the same symptoms - a constant drip drip drip of negativity fueled by wild speculation and untruths.

Things like "placing imminent" when there's funding for 3 years even with no revenue.

Saying "No revenue for 3 years" when there's already revenue from Go Figure products that are about to go into another 200 stores, and when supply has already been made of LPLDL to generate revenue, and it only launched yesterday.

Things like "All the big boys will blow you out of the water" when the IP is absolutely watertight. It's a combination of bacteria species for goodness sake - how can you replicate that without using the same species? It's rather an easy infringement to prove.

I have managed to convince myself that OPTI:Optibiotix is under attack, and that makes me very angry. When someone's trying to screw you, you fight back. The only way I know to fight back is to take advantage of the shares being so cheap and buy more. Then when the attack stops, I'll be sure to have the last laugh - and my laugh will go on for decades!

First I had to find something I was willing to sell. That's easier said than done at the moment. I looked to my SIPP. Altogether I had over 150,000 shares in JLP:Jubilee Platinum, which has heaps of promise, but has tried my patience lately. Every time there seems to be a breakthrough or ground breaking news, the BoD manage to do something daft and the price gets clobbered again. I still think this will be a great share, but less great than OPTI:Optibiotix, so I sold the 55,306 in my SIPP for 4.4p after paying 4.22 and made a spectacular £69.26 (2.9%) profit. Frustrating given that it was making about £800 profit a few weeks ago! This liberated £2,421.51 for me to invest in OPTI:Optibiotix.

I bought 3,597 shares at 64.28p costing £2,324.10. I wanted more, but frustratingly they were not available to buy from an online quote this morning so I had to leave a limit order. Good news was my limit order was 66p which I thought was a bargain, and the price dropped even further so I got them cheaper, but have a small amount of cash stranded in my SIPP now until I sell something else. This purchase took my average price in the SIPP from 71.83p to 69.18p, so a return to the low 70's will put them in profit. For now they are losing £911 as the bid price has dropped to 61p - bugger!

As soon as the email came through confirming the limit order had been dealt and I saw the price, I grabbed my mobile phone and executed Plan B. After the misery of Brexit, TW.:Taylor Wimpey had finally climbed back to the 200p I bought them for, and when dividends are included were up by £42.09, with another dividend on the way soon, even if I sell now. I regretted buying housebuilder shares almost as soon as I got them. They pay great dividends but they are so volatile with the slightest change in sentiment of the housing market or interest rates or tax laws. Absolute nightmare,  and I've wanted out but wouldn't take a loss. I sold my 600 shares today for 201.33p which without dividends was a £23.37 loss, basically the commission and amounts to 1.5%. This liberated £1,196.03 in my ISA. I could now get an online quote, so bought 1,848 OPTI:Optibiotix at 64.27p costing £1,199.66. This took my average ISA price from 78.7p to 76.15p. Given I bought a lot of these at 90p, this is a great result. The ISA holding is now losing £1,649.40 - Grr!

So, OPTI:Optibiotix now makes up 27.1% of my combined portfolios with 22,737 shares making a total paper loss of £2,681.78. What was that about a max 10% rule?

Ahahahahahahahahahaha!!!!!!!! What have I done?!

My shares in OPTI spin-off SBTX:SkinBiotherapeutics are down by 34% and losing £353,28 so between them they are down by three grand.

Ahahahahahahahahahaha!!!!!!!!

I just don't care - well - actually I do care quite a lot. I feel an anger and frustration deep deep down that the world can't see the promise about to explode from this company. Maybe it can see, but chooses to watch like a predator for the right moment to pounce. Kinda wish I'd done that now, but regret will evaporate if I get a bucket load of free SBTX:SkinBiotherapeutics shares for being invested here for so long.

That's it - Monday gave a great buffer, with combined portfolios up £800 from last week's catastrophe, but £500 of that vanished yesterday and another £700 today, so we're £388 in the red for the week and £1,732 in the red overall. I would have been feeling depressed and miserable after this week's price drops, but instead I feel elated and brimming with confidence that the worm will soon turn, and when it does it will be like one of them from Tremors and scoff everything in its path!

Week 91 Review - Horrid

This has been an utterly catastrophic week, with one of the biggest declines in portfolio value since I started investing. The combined portfolios crashed in value by £2,986.55 leaving them £1,344.04 in the red. This wasn't helped by cashing in about £700 profit, but that's still well over £2,000 down.

Just a fleeting dalliance above the red line. It looked so bright a few weeks ago, but now despair has set in.

Amazingly there was only one double-digit loser amongst the declines, with JLP:Jubilee Platinum declining 10%, but in my SIPP the effect of bedding my share account holdings into my existing ISA holding  meant the value dropped by 26% compared with the cost. There were 5% and 6% drops in a large number of shares to drag down the overall performance

The share and ISA accounts look like this

			Weekly Change
Portfolio cost	£42,576.65		+£446.39
Portfolio sell value (bid price - commission)	£39,950.90	(-6.2%)	-£1,645.20
Potential profits	£3,505.25		-£944.76
Yr 2 Dividends	£365.04		+£0
Yr 2 Profit from sales	£2,424.43		+£34.87
Yr 2 Average monthly cash profit	£306.61		-£4.09
Yr 2 Avg annual % of current portfolio cost	8.6%
Total Dividends	£1,032.97		+£7.94
Total Profit from sales	£6.264.69		+£34.87
Average monthly cash profit	£343.21		-£2.13
(Sold stocks profit + Dividends - Fees / Months)
Avg annual % of current portfolio cost	9.7%

Portfolio cost went up when the JLP:Jubilee Platinum shares from my trading account got moved into my ISA. Massive drop in value, over half of which was loss of potential profit which is very painful. £34.87 was the profit I made from selling JLP:Jubilee Platinum as part of the bedding.

That's a steeper fall than when Trump got elected!

The SIPP looks like this after week 75

			Weekly Change
Portfolio cost	£17,496.86		+£720.17
Portfolio sell value (bid price - commission)	£18,959.45	(+8.4%)	-£1,354.89
Potential profits	£2,626.33		-£1,108.21
Yr 2 Dividends	£0		+£0
Yr 2 Profit from sales	£1,527.55		+£685.48
Yr 2 Average monthly cash profit	£279.71		+£120.87
Yr 2 Avg annual % of current portfolio cost	19.2%
Total Dividends	£413.19		+£0
Total Profit from sales	£3,877.41		+£685.48
Average monthly cash profit	£242.49		+£36.44
(Sold stocks profit + Dividends - Fees / Months)
Avg annual % of current portfolio cost	16.6%

The sale of CWR:Ceres Power did great things for my performance, but savaged the paper profits. Even without the sale they would have fallen £400 which is a lot for this portfolio.

The lines are irresistibly attracted to each other!

The trading account looks like this after week 41

			Weekly Change
Portfolio cost	£986.03		-£495.95
Cash	£79.63		+£0
Portfolio sell value (bid price - commission)	£805.14	(-18.3%)	-£482.42
Potential profits	£0		+£0
Dividends	£0		+£0
Profit from sales	-£22.85		-£84.42
Average monthly cash profit	-£2.42		-£9.09
(Sold stocks profit + Dividends - Fees / Months)
Avg annual % of current portfolio cost	-2.9%

My desire to bed JLP:Jubilee Platinum into my ISA as a long term holding meant I was willing to savage my profits and cut the capital invested back to the £1,000 that was meant to be used to seed this account. I need something amazing to happen to KIBO:Kibo Mining or REDS:RedstoneConnect in the next 11 weeks or my first annual trading report will be embarrassing!

Yeah whatever...

I'm not going to write anything about how excited I am for what's going to happen next week. OPTI:Optibiotix launch the new cholesterol product, so hopefully the current share price madness will reverse, and maybe they will announce how we're getting free SBTX:SkinBiotherapeutics shares.

KIBO:Kibo Mining announced the reverse takeover of OPRA:Opera Investments today, so KAT:Katoro Mining will start trading on 23rd May. Will we get free shares out of the 61 million Kibo will be allocated?

I don't want another week like this one thank you very much.